TWA
NUVB icon

TCI Wealth Advisors’s Nuvation Bio NUVB Stock Holding History

TCI Wealth Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,043
Closed -$3.39K – 1531
2023
Q1 		$3.39K Buy
+2,043
New +$4.14K ﹤0.01% 1782
2022
Q1 		– Sell
-504
Closed -$4K – 2379
2021
Q4 		$4K Buy
+504
New +$4.63K ﹤0.01% 1861

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

TCI Wealth Advisors's NUVB Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Nuvation Bio (NUVB) in Q2 2023, closing a stake of 2,043 shares — an estimated $3.39K sold.

TCI Wealth Advisors first reported a position in NUVB in Q4 2021 and held it in 2 quarters. The position peaked at $4K in Q4 2021. 124 funds tracked by Wall St. Rank hold NUVB as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Nuvation Bio position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 2,043 Nuvation Bio shares in Q2 2023, an estimated $3.39K.
  • TCI Wealth Advisors first reported a position in Nuvation Bio in Q4 2021 and held it in 2 quarters.
  • TCI Wealth Advisors's Nuvation Bio position peaked at $4K in Q4 2021.
  • 124 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.